Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IPILIMUMAB vs IPRAGLIFLOZIN L-PROLINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IPILIMUMAB vs IPRAGLIFLOZIN L-PROLINE: Safety Overview

Metric IPILIMUMAB IPRAGLIFLOZIN L-PROLINE
Total FAERS Reports 36,528 124
Deaths Reported 8,043 9
Death Rate 22.0% 7.3%
Hospitalizations 17,031 74
Average Patient Age 62.9 yrs 62.1 yrs
% Female Patients 35.4% 37.6%
Manufacturer E.R. Squibb & Sons, L.L.C. N/A
Route INTRAVENOUS N/A
Marketing Status Prescription N/A